Type 2 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have normal or slightly elevated fasting blood sugar levels, and normal or slightly impaired ability to process sugar after eating
Who may not be able to join:
- People whose HbA1c blood sugar test result is above 6.5% (a measure of average blood sugar over several months)
- People with a BMI of 35 or higher
- People currently taking any medication that lowers blood sugar, including metformin or sulfonylureas
- Women who test positive for pregnancy at the time of joining or during the study
- People who have previously had upper abdominal surgery, such as gastric banding, pyloroplasty, or vagotomy
- People who currently have an active serious illness or cancer
- People who have noticeable symptoms from disease affecting large or small blood vessels (confirm with trial site)
- People whose hematocrit (a measure of red blood cells in the blood) is below 35%
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Adrian Vella, MD, Mayo Clinic
Phone: 507-255-0907
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Suppression of Endogenous glucose production (EGP) by insulin; Insulin pulse orderliness
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.